RenovoRx   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Los Altos CA United States (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2012
NCT00978302
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Renovo | Renovo Clinical Trials Unit | Renovo Ltd | RenovoRx